GlassScriptPhysician profile
Robert Joseph Moses
NPI 1790717866
$3,110.63
in general payments reported to CMS, 2019-2025
18 companies · $639 in 2025
The $639 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $38.80 · 2021: $350 · 2022: $158 · 2023: $694 · 2024: $780 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $175 · Entertainment: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,787.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $175.00 |
| Entertainment | $150.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $532.73 | 2022-2025 | Infuse, Infuse Multifocal, Vyzulta |
| Alcon Vision LLC | $422.79 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Coopervision INC. | $412.36 | 2022-2024 | Misight Contact Lens, Myday Contact Lens |
| Glaukos Corporation | $308.43 | 2019-2023 | |
| Allergan, INC. | $264.24 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $262.88 | 2025 | Acthar |
| Optos, INC. | $174.43 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $125.00 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $105.08 | 2024 | |
| Abb Con-Cise Optical Group LLC | $102.43 | 2021 | |
| Maculogix, INC. | $100.04 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $91.51 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $57.82 | 2021-2023 | |
| Johnson & Johnson Vision Care, INC. | $51.16 | 2023 | Acuvue |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $26.04 | 2024 | Vevye |
| Aerie Pharmaceuticals, INC. | $17.94 | 2021 | |
| Kala Pharmaceuticals, INC. | $16.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.